Computational analyses of aortic blood flow under varying speed CF-LVAD support.

Comput Biol Med

Thermo Fluid Mechanics Research Centre (TFMRC), University of Sussex, Falmer, BN1 9RS, UK. Electronic address:

Published: December 2020

Continuous Flow Left Ventricular Assist Devices (CF-LVADs) generally operate at a constant speed whilst supporting a failing heart. However, constant speed CF-LVAD support may cause complications and increase the morbidity rates in the patients. Therefore, different varying speed operating modes for CF-LVADs have been proposed to generate more physiological blood flow, which may reduce complication rates under constant speed CF-LVAD support. The proposed varying speed CF-LVAD algorithms simulate time-dependant dynamics and three dimensional blood flow patterns in aorta under varying speed CF-LVAD support remain unclear. The aim of this study is to evaluate three dimensional blood flow patterns in a patient-specific aorta model under co-pulsating and counter-pulsating CF-LVAD support modes driven by speed and flow rate control algorithms using numerical simulations. Aortic blood flow was evaluated for 10,000 rpm constant speed CF-LVAD support generating 4.71 L/min mean flow rate over a cardiac cycle. Co-pulsating and counter-pulsating CF-LVAD speed control operated the pump at the same average speed over a cardiac cycle and co-pulsating and counter-pulsating CF-LVAD flow rate control generated the same average flow rate over cardiac cycle as in the constant speed pump support. Simulation results show that the utilised counter-pulsating pump flow rate control may decrease the haemolysis to a third compared to the most commonly employed constant speed pump operating mode. Moreover, CF-LVAD support utilising counter-pulsating pump flow rate control generated the most favourable hemodynamic characteristics, i.e. low Dean number, least wall shear stress and least haemolysis values among the investigated cases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2020.104058DOI Listing

Publication Analysis

Top Keywords

cf-lvad support
28
speed cf-lvad
24
constant speed
24
flow rate
24
blood flow
20
varying speed
16
rate control
16
speed
13
flow
12
co-pulsating counter-pulsating
12

Similar Publications

Stroke continues to be a major adverse event in advanced congestive heart failure (CHF) patients after continuous-flow left ventricular assist device (CF-LVAD) implantation. Abnormalities in mitochondrial oxidative phosphorylation (OxPhos) have been critically implicated in the pathogenesis of neurodegenerative diseases and cerebral ischemia. We hypothesize that prior stroke may be associated with systemic mitochondrial OxPhos abnormalities, and impaired more in post-CF-LVAD patients with risk of developing new stroke.

View Article and Find Full Text PDF
Article Synopsis
  • A significant number of heart failure patients progress to advanced stages, which heightens health risks, and some may qualify for advanced treatments like ventricular assist devices (VAD).
  • This study assessed vascular function in 34 patients with VAD compared to 34 patients with advanced heart failure, finding that those with VAD showed improved endothelial function in larger arteries but not in microcirculation.
  • The findings suggest that while VAD implantation benefits endothelial function at the arterial level, it does not enhance microvascular function in advanced heart failure patients.
View Article and Find Full Text PDF

Background: Vasoplegia after cardiac surgery is associated with adverse outcomes. However, the clinical effects of vasoplegia and the significance of its duration after continuous-flow left ventricular assist device (CF-LVAD) implantation are less known.

Objectives: This study aimed to identify predictors of and outcomes from transient vs prolonged vasoplegia after CF-LVAD implantation.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the predictability and outcomes of explanting continuous flow left ventricular assist devices (cf-LVAD) in patients with non-ischaemic dilated cardiomyopathy who show signs of myocardial recovery.
  • *It found that the time between the first heart failure event and cf-LVAD implantation is a key predictor of successful device removal, with a crucial cutoff point of 7 months.
  • *After successful explantation, patients showed significant improvement in heart function and were hospitalized-free from heart failure, indicating that early intervention may lead to better recovery outcomes.
View Article and Find Full Text PDF

Centrifugal-flow left ventricular assist devices (CF-LVADs) have improved morbidity and mortality for their recipients. Hospital readmissions remain common, negatively impacting quality of life and survival. We sought to identify risk factors associated with hospital readmissions among patients with CF-LVADs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!